Drugs for diabetes

Details Drugs for diabetes Drugs for diabetes

2001-10-09

2008-05-27

Weddington, Kevin E. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S357000, C514S509000, C514S866000

Reexamination Certificate

active

07378437

ABSTRACT:
Use for the diabetes treatment of compounds or salts thereof, having the following general formula (I): A-(B)b0—(C)c0—NO2wherein A contains the radical of a drug having an antiinflammatory or analgesic activity, B is a bivalent linking group wherein the precursor must meet the tests described in the application, C is a a bivalent linking group as defined in the invention.

REFERENCES:
patent: 4452806 (1984-06-01), Rizzi et al.
patent: 5518998 (1996-05-01), Backstrom et al.
patent: 5597847 (1997-01-01), Matji et al.
patent: 5861426 (1999-01-01), Del Soldato et al.
patent: 6040341 (2000-03-01), Del Soldato et al.
patent: 6054587 (2000-04-01), Reddy et al.
patent: 6211233 (2001-04-01), Del Soldato
patent: 6613784 (2003-09-01), Benedini et al.
patent: 0 578 494 (1994-01-01), None
patent: 00/61537 (2000-10-01), None
Bailey “Potential new treatments for type 2 diabetes”, Trends in Pharm. Sci., vol. 21, pp. 259-265, 2000.
“Antidiabetic Agents”, Martindale, the Extra Pharmacopoeia, pp. 342-343, 1996.
The Merck Index, XII Ed., 1996.
Nenseter, et al., “Paracetamol Inhibits Copper Ion-Induced, Azo Compound-Initiated, and Mononuclear Cell-Mediated oxidative Modification of LDL”, Atheroscler, Thromb. 15, pp. 1338-1344, 1995.
Facino et al., “Hydroxynimesulide, The Main Metabolite of Nimesulide, Prevents Hydroperoxide Hemoglobin-Induced Hemolysis of Rat Erythrocytes”, Drugs Exptl. Clin. Res. XXIII (5/8), pp. 157-165, 1997.
Greene, “Protective groups in organic synthesis”, Harward University Press, 1980.
Remington's Pharmaceutical Sciences, 15th Edition.
Physician's Desk Reference.
Katakam et al., “Endothelial dysfunction precedes hypertension in diet-induced insulin resistance”, Am. J. Physiol. 275, R788-R792, 1998.
Tashima et al., “Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats”, Life Sciences 67: 1639-1652 (2000).

Affiliated with

Also associated with

Rating

Drugs for diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drugs for diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs for diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3983558